Oramed Pharmaceuticals Inc (ORMP)
2.33
+0.02
(+0.87%)
USD |
NASDAQ |
Nov 22, 09:40
Oramed Pharmaceuticals Market Cap: 93.93M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 93.12M |
| November 20, 2024 | 91.11M |
| November 19, 2024 | 92.72M |
| November 18, 2024 | 87.48M |
| November 15, 2024 | 89.90M |
| November 14, 2024 | 94.13M |
| November 13, 2024 | 93.52M |
| November 12, 2024 | 94.33M |
| November 11, 2024 | 93.52M |
| November 08, 2024 | 93.12M |
| November 07, 2024 | 95.94M |
| November 06, 2024 | 94.09M |
| November 05, 2024 | 94.49M |
| November 04, 2024 | 96.10M |
| November 01, 2024 | 93.29M |
| October 31, 2024 | 95.70M |
| October 30, 2024 | 96.91M |
| October 29, 2024 | 92.08M |
| October 28, 2024 | 93.29M |
| October 25, 2024 | 95.10M |
| October 24, 2024 | 94.89M |
| October 23, 2024 | 95.70M |
| October 22, 2024 | 95.30M |
| October 21, 2024 | 94.29M |
| October 18, 2024 | 93.09M |
| Date | Value |
|---|---|
| October 17, 2024 | 96.50M |
| October 16, 2024 | 97.71M |
| October 15, 2024 | 94.49M |
| October 14, 2024 | 95.70M |
| October 11, 2024 | 95.70M |
| October 10, 2024 | 95.50M |
| October 09, 2024 | 96.50M |
| October 08, 2024 | 93.69M |
| October 07, 2024 | 96.91M |
| October 04, 2024 | 94.49M |
| October 03, 2024 | 96.91M |
| October 02, 2024 | 96.10M |
| October 01, 2024 | 96.50M |
| September 30, 2024 | 98.11M |
| September 27, 2024 | 101.11M |
| September 26, 2024 | 97.85M |
| September 25, 2024 | 97.44M |
| September 24, 2024 | 95.81M |
| September 23, 2024 | 94.79M |
| September 20, 2024 | 94.18M |
| September 19, 2024 | 100.70M |
| September 18, 2024 | 98.66M |
| September 17, 2024 | 102.33M |
| September 16, 2024 | 101.11M |
| September 13, 2024 | 101.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
44.50M
Minimum
Nov 22 2019
1.132B
Maximum
Nov 08 2021
216.64M
Average
113.45M
Median
Mar 21 2024
Market Cap Benchmarks
| Skye Bioscience Inc | 125.90M |
| Scilex Holding Co | 69.81M |
| NovaBay Pharmaceuticals Inc | 3.425M |
| Palatin Technologies Inc | 18.14M |
| iBio Inc | 22.23M |
Market Cap Related Metrics
| PE Ratio | 21.18 |
| PS Ratio | 35.68 |
| Price to Book Value | 0.6004 |
| Price | 2.33 |
| Earnings Yield | 4.72% |